| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/02/2002 | EP1165561A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents |
| 01/02/2002 | EP1165554A1 New endothelin converting enzyme inhibitors, their production and their use |
| 01/02/2002 | EP1165553A1 C10 ester substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165552A1 C7 carbonate substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165551A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165550A1 C10 carbonate substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165549A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165544A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase |
| 01/02/2002 | EP1165537A1 Hydroxymatairesinol in cancer prevention |
| 01/02/2002 | EP1165534A2 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
| 01/02/2002 | EP1165531A1 N-adamant-1-yl-n'- 4-chlorobenzothiazol-2-yl] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent |
| 01/02/2002 | EP1165514A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |
| 01/02/2002 | EP1165513A1 Indolinone compounds as kinase inhibitors |
| 01/02/2002 | EP1165508A1 Anticancer calcium channel blockers |
| 01/02/2002 | EP1165506A1 Substituted azetidin-2-ones as cysteine protease inhibitors |
| 01/02/2002 | EP1165504A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
| 01/02/2002 | EP1165500A1 Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase |
| 01/02/2002 | EP1165493A1 Nitrogen mustard compounds and prodrugs therefor |
| 01/02/2002 | EP1165185A2 Human tumor necrosis factor receptor-like 2 |
| 01/02/2002 | EP1165143A2 Method for expressing proteins |
| 01/02/2002 | EP1165140A2 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 01/02/2002 | EP1165139A2 Pharmaceutical compositions comprising in combination a bisphosphonate and a matrix metalloproteinasese inhibitor |
| 01/02/2002 | EP1165137A1 Sphingomyelin containing preparation for the enhancement of tumor therapy |
| 01/02/2002 | EP1165134A1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
| 01/02/2002 | EP1165132A2 Dry formulation for transcutaneous immunization |
| 01/02/2002 | EP1165117A1 Interferon-beta use in the treatment of ewing's family of tumors |
| 01/02/2002 | EP1165115A1 Modulation of vascular permeability by mean of tie2 receptor activators |
| 01/02/2002 | EP1165108A1 Use of a serenoa repens extract for the production of a medicament to treat prostate cancer |
| 01/02/2002 | EP1165106A2 Composition and method for inducing apoptosis in prostate cancer cells |
| 01/02/2002 | EP1165098A2 Peroxovanadium compounds as antineoplastic agents for the treatment of cancer |
| 01/02/2002 | EP1165096A2 Use of cytidine derivatives for the treatment of leukaemia |
| 01/02/2002 | EP1165092A1 Cyclopentanone derivatives and their use |
| 01/02/2002 | EP1165085A1 Phthalazine derivatives for treating inflammatory diseases |
| 01/02/2002 | EP1165084A1 Inhibitors of prenyl-protein transferases |
| 01/02/2002 | EP1165082A1 Inhibitors of prenyl-protein transferase |
| 01/02/2002 | EP1165078A1 Methods of inducing cancer cell death and tumor regression |
| 01/02/2002 | EP1165071A2 Improved cancer treatment with temozolomide |
| 01/02/2002 | EP1165070A1 Thiadiazolyl urea or thiourea derivatitives for antiviral treatment |
| 01/02/2002 | EP1165069A1 Antitumour synergistic composition |
| 01/02/2002 | EP1165068A1 C10 heterosubstituted acetate taxanes as antitumor agents |
| 01/02/2002 | EP1165067A1 A process for the preparation of aziridinyl epothilones from oxiranyl epothilones |
| 01/02/2002 | EP1165059A1 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis |
| 01/02/2002 | EP1165013A2 Inhibitors of prenyl-protein transferase |
| 01/02/2002 | EP1164991A1 Gels formed by the interaction of poly(aldehyde) with various substances |
| 01/02/2002 | EP1135151A4 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 01/02/2002 | EP1079849B1 Use of hmg proteins for the preparation of medicaments having cytotoxic activity |
| 01/02/2002 | EP1005372B1 Anti-cd40l immunotoxins for the treatment of diseases |
| 01/02/2002 | EP0983273B1 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 01/02/2002 | EP0958307B1 O-sulfated bacterial polysaccharides |
| 01/02/2002 | EP0892801B1 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 01/02/2002 | EP0785938B1 Fused pyrrolocarbazoles |
| 01/02/2002 | EP0745074B1 4-amino derivatives of mycophenolic acid with immunosuppressant activity |
| 01/02/2002 | CN1329616A Acylated benzylmal tosides as inhibitors of smooth muscle cell proliferaton |
| 01/02/2002 | CN1329610A Chromenone and chromanone derivatives as integrin inhibitors |
| 01/02/2002 | CN1329607A Substituted benzopyran analogs for treatment of inflammation |
| 01/02/2002 | CN1329601A New benzimidazolone-benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 01/02/2002 | CN1329506A Formulation with an improved therapeutic range, cntainng nucleotide synthesis inhibitors |
| 01/02/2002 | CN1329504A F1t4(VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 01/02/2002 | CN1329499A Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 01/02/2002 | CN1329498A Cancer treatment composition and method using natural plant essential oils |
| 01/02/2002 | CN1329497A Cmbination therapy to treat hepatitis b virus |
| 01/02/2002 | CN1329493A Methods and compositions for restoring conformational stability of a protein of the p53 family |
| 01/02/2002 | CN1329491A Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 01/02/2002 | CN1329489A Methods and compositions for selective cancer chemotherapy |
| 01/02/2002 | CN1329488A Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| 01/02/2002 | CN1329485A Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period |
| 01/02/2002 | CN1329167A A novel polypeptide-human non-integral protein-metalloprotease 10.67 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329166A A novel polypeptide-human non-integral protein-metalloprotease 11.11 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329148A A novel polypeptide-human NADH dehydrogenase subunit I-9 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329142A A novel polypeptide-RNA polymerase II related protein 11.33 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329092A A novel polypeptide-human RS3 protien 18 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329091A A novel polypeptide-human tropobidin 9 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329086A A novel polypeptide-human TNFR/NGFR protein 15 contaiing cytochrome C structural domain and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329069A A novel polypeptide-human PLP protein 39 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329045A A novel polypeptide-mouse zinc finger protein (Zfp-1) protein 16 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329044A A novel polypeptide-human shearing factor 9.24 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329043A A novel polypeptide-human L1 factor ORF2 inversed transcriptive related protein 15 and plynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329042A A novel polypeptide-human zinc finger protein FPM 315-17 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329040A A novel polypeptide-human L1 factor ORF2 inversed transcriptive related protein 13 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329038A A novel polypeptide-human ribonucleoside diphosphate kinase arrestin 10.23 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329034A A novel polypeptide-human L1 components ORF2 protein 21 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329031A A novel polypeptide-human RNA conjugated protein 19 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329027A A novel polypeptide-human lymph enhancer 42 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329024A A novel polypeptide-activating GTP enzyme protein negative regulatory factor 11.66 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329018A A novel polypeptide-phytochrome 9.9 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329012A A novel polypeptide-nicotinamide adenine deoxydinucleotide dependent leukotriene B412-hydroxydehydrogenase 36 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329011A A novel polypeptide-mouse transient receptor potential protein 2(Trp2)12 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329009A A novel polypeptide-avidin 9 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329008A A novel polypeptide-H1yD protein family secretory protein 11 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1328849A Medicine for curing cancers and its preparation method |
| 01/02/2002 | CN1328842A Medicine for curing malignant tumor and its preparation method |
| 01/02/2002 | CN1076967C Use of droloxifene for treatment of cardiovascular diseases |
| 01/01/2002 | US6335427 Component of stem bromelain |
| 01/01/2002 | US6335358 Lactacystin analogs |
| 01/01/2002 | US6335343 Inhibitors of prenyl-protein transferase |
| 01/01/2002 | US6335342 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 01/01/2002 | US6335338 Calcilytic compounds |
| 01/01/2002 | US6335333 Matrix metalloproteinase inhibitors |
| 01/01/2002 | US6335332 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 01/01/2002 | US6335329 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |